Key result
Higher SBP post-ROSC is linked to ~32% greater survival, while low SpO2 decreases survival.
Why the study?
Early post-ROSC physiology changes rapidly, but most studies rely on a single handover set of vital signs, missing physiologic trajectories and cumulative exposure to hypotension or hypoxemia.
Are early post-ROSC minute-level physiologic trajectories (hypotension and hypoxaemia) associated with survival to hospital discharge in patients with out-of-hospital cardiac arrest?
Are early post-ROSC minute-level physiologic trajectories (hypotension and hypoxaemia) associated with survival to hospital discharge in patients with out-of-hospital cardiac arrest?
High-fidelity minute-level monitoring reveals that cumulative exposure to early post-ROSC hypotension and hypoxaemia is strongly associated with decreased survival to hospital discharge in out-of-hospital cardiac arrest.
Supports avoiding early post-ROSC hypotension and hypoxaemia; extends prior OHCA studies with high-fidelity minute-level cumulative exposure data.
• Registry-linked, ROSC-aligned, minute-by-minute Zoll® monitor-defibrillator data. • Enables cumulative exposure metrics for hypotension, hypoxaemia and ETCO 2. • Higher SBP/MAP and SpO 2 were associated with greater survival to hospital discharge. • Higher mean ETCO 2 was inversely associated with survival. • Neurological associations among survivors were smaller, mainly limited to SBP. Early post-ROSC physiology changes rapidly, but most studies rely on a single handover set of vital signs, which can miss trajectories and time spent hypotensive or hypoxemic. We aimed to describe minute-level early post-ROSC blood pressure and oxygenation and examine their association with outcomes. Retrospective cohort study of out-of-hospital cardiac arrest in Victoria, Australia (2019 to 2023). We linked the Victorian Ambulance Cardiac Arrest Registry to Zoll® monitor-defibrillator recordings, aligned measurements to recorded ROSC, aggregated readings into 1-minute bins, and derived per-patient mean, minimum, and minutes below thresholds for SBP, MAP and SpO 2 . Associations with outcomes were modelled using adjusted logistic regression. Primary outcome was survival to hospital discharge. Secondary outcome was good 12-month neurological outcome among survivors. Among 3,694 patients with sustained ROSC, 1,444 survived. Median ROSC-to-arrival was 58 minutes. Median per patient was 36 blood pressure and 97 SpO 2 values. Compared with SBP 100 mm Hg, survival was lower at 80 mm Hg (aOR 0.87, 95% CI 0.79 to 0.95) and higher at 140 mm Hg (aOR 1.32, 95% CI 1.11 to 1.59). SpO 2 90% versus 95% was associated with lower survival (aOR 0.70, 95% CI 0.63 to 0.79). Longer time with SBP <90 mm Hg, MAP <65 mm Hg, or SpO 2 <90% was associated with lower survival. Associations with good 12-month neurological outcome were smaller and mainly limited to blood pressure. Minute-level monitor-defibrillator data showed strong associations between early hypotension and hypoxaemia and survival after ROSC and allow cumulative exposure to be quantified.
No takes yet. Share an insight, caveat, or question.
Fouche et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: